StockSelector.com
  Research, Select, & Monitor Friday, February 15, 2019 3:00:25 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
   Diversify with StockSelector.com
- the tools for short-term traders and long-term investors to find successful ideas to fit their strategies and to keep informed of the stocks you follow or hold. Take a macro look at the market and by industry, narrow down to specific stocks and the right time, then use our portfolio to monitor the stocks and be alerted of changes.


 Sector ETF's Price Change  
S&P 500 Cons Disc Sector SPDR 110.01 0.64%
S&P 500 Cons Staples Sector SPDR 54.31 0.87%
S&P 500 Energy Sector SPDR 65.91 1.29%
S&P 500 Financials Sector SPDR 26.38 1.93%
S&P 500 Healthcare Sector SPDR 92.63 1.27%
S&P 500 Industrial Sector SPDR 75.43 0.99%
S&P 500 Materials Sector SPDR 54.25 0.93%
S&P 500 Info Tech Sector SPDR 69.49 0.61%
S&P 500 Utilities Sector SPDR 55.56 0.04%

 Most Oversold Industry
 Auto Manufacturers - Major
These firms are some of the largest vehicle manufacturers in the world. They produce the obvious cars, trucks, buses, vans, and motorcycles. Recreational vehicles, mini-vans, luxury cars, components, and construction equipment are some of their other related items on the production lines. Many firms also offer financing of their goods and in a field tied to vehicle financing, one firm here offers mortgages and even auto and homeowner's insurance. They typically sell their product to the consumer through auto dealerships located domestically and abroad.


Snap Reports In-line
2/5/2019 4:10:00 PM


0.44%
Snap Inc. (SNAP) reported a fourth quarter loss of $0.04 per share on revenue of $389.8 million. The consensus earnings estimate was a loss of $0.08 per share on revenue of $376.6 million for the quarter ending December 31, 2018. The ... more

Apple Reports & Guides In-line
1/29/2019 4:30:00 PM


0.24%
Apple, Inc. (AAPL) reported first quarter earnings of $4.18 per share on revenue of $84.3 billion. The consensus earnings estimate was $4.17 per share on revenue of $84.1 billion for the quarter ending December 31, 2018. The Earnings ... more

Brinker Misses
1/29/2019 6:45:00 AM



1.07%
Brinker International, Inc. (EAT) reported second quarter earnings of $0.89 per share on revenue of $790.7 million. The consensus earnings estimate was $0.88 per share on revenue of $778.8 million for the quarter ending December 31, ... more

Freeport-McMoRan Misses
1/24/2019 8:00:00 AM



1.07%
Freeport-McMoRan Copper & Gold, Inc. (FCX) reported fourth quarter earnings of $0.11 per share on revenue of $3.68 billion. The consensus earnings estimate was $0.21 per share on revenue of $3.93 billion for the quarter ending December ... more

P&G Beats
1/23/2019 7:00:00 AM


0.06%
Procter & Gamble Co. (PG) reported second quarter earnings of $1.25 per share on revenue of $17.44 billion. The consensus earnings estimate was $1.21 per share on revenue of $17.20 billion for the quarter ending December 31, 2018. The ... more

Citigroup Beats by a Penny
1/14/2019 7:59:00 AM



2.96%
Citigroup, Inc. (C) reported fourth quarter earnings of $1.61 per share on revenue of $17.12 billion. The consensus earnings estimate was $1.55 per share on revenue of $17.59 billion for the quarter ending December 31, 2018. The Earnings ... more

 StockSelector's Top Ranked Stock
 Axcelis Technologies, Inc.
Positive Points:20
Negative Points:4
Axcelis Technologies is a leading producer of ion implantation equipment used in the fabrication of semiconductors. The company also produces dry strip, photostabilization and rapid thermal processing equipment, which is used in semiconductor manufacturing primarily before and after the ion implantation process. In addition, the company provides extensive aftermarket service and support, including spare parts, equipment upgrades, maintenance services and customer training.

 Potential Breakout Stock
 Rexahn Pharmaceuticals Inc
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.











Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Quotes are delayed by 15-20 minutes. Quotes provided by QuoteMedia

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.